Boc-Gly-Pro-OH

Boc-Gly-Pro-OH is a protected dipeptide acid featuring a Boc-protected N-terminus and a glycine-proline sequence, provided as a carboxylic acid suitable for further peptide assembly. The presence of the Boc group supports controlled stepwise coupling strategies, while proline's cyclic secondary amine side chain and conformationally constrained structure make this building block useful for constructing peptides where turn formation and backbone rigidity are important. As a peptide intermediate rather than a free amino acid, it is typically selected for downstream peptide synthesis workflows that require a defined N-protected, C-terminally functionalized segment.

1. Solution-Phase Peptide Coupling

Boc-Gly-Pro-OH is widely used by peptide chemistry groups performing solution-phase segment assembly, where the Boc-protected N-terminus helps manage chemoselectivity during sequential couplings. Researchers incorporate this glycine-proline unit to build peptide intermediates with defined stereochemical and connectivity features, particularly when proline-containing motifs are needed to control local conformation. The C-terminal carboxylic acid functionality enables activation and condensation into longer peptide chains, supporting workflows that prioritize modular synthesis and reproducible intermediate generation for structure-activity relationship studies.

2. Solid-Phase Peptide Segment Building

Boc-Gly-Pro-OH is commonly employed as a protected peptide segment in solid-phase peptide synthesis strategies that require defined dipeptide incorporation prior to or during chain elongation. Peptide manufacturers and custom synthesis teams use this building block to introduce a glycine-proline sequence with the N-terminus protected by Boc, aligning with standard deprotection and coupling cycles used to assemble peptides of interest. The proline residue is especially valuable in this context because its conformational constraint often improves the formation of turns or influences peptide folding patterns, making this segment a practical choice for generating peptide libraries and defined analogs.

3. Peptide Library Intermediate Preparation

Boc-Gly-Pro-OH is frequently selected for preparing intermediate stocks used in parallel peptide synthesis and medicinal chemistry hit-to-lead campaigns, where consistent incorporation of a glycine-proline motif is required across multiple analogs. By using a preassembled, N-protected dipeptide acid, developers reduce variability associated with assembling short sequences from individual amino acids, improving batch-to-batch reproducibility of key intermediates. The resulting defined segment supports downstream diversification at other positions of the peptide, enabling systematic evaluation of sequence effects on structure and properties during lead optimization.

4. Conformationally Constrained Motif Synthesis

Boc-Gly-Pro-OH serves as a targeted building block for constructing peptides that include proline-containing conformational motifs, where backbone rigidity and turn propensity are key design considerations. Chemical biology and protein engineering laboratories use this segment to generate peptides that probe how local sequence constraints affect structure, recognition, or interaction patterns in experimental systems. The glycine-proline combination is particularly useful for introducing a flexible residue adjacent to a constrained proline, supporting controlled spacing and backbone geometry in synthetic peptide constructs used for mechanistic studies and binding assays.

1. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I

2. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

3. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

4. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

5. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation